Pharmacist prescribers Linda Bryant and Leanne Te Karu discuss positive polypharmacy for heart failure. Current evidence shows the intensive implementation of four medications offers the greatest benefit to most patients with heart failure, with significant reductions in cardiovascular mortality, heart failure hospitalisations and all-cause mortality
ProCare welcomes the reduction in age of bowel screening for Māori and Pacific patients; long overdue
+Undoctored
ProCare welcomes the reduction in age of bowel screening for Māori and Pacific patients; long overdue
Thursday 19 May 2022, 03:20 PM

Leading healthcare provider ProCare has today welcomed the reduction in the age of bowel screening for Māori and Pacific patients from 60 to 50 with an additional $10.096 million in the next financial year.
Dr Allan Moffitt, Clinical Director at ProCare says: “This decision has been long overdue, and we have been lobbying for this reduction in screening age for a number of years now.
“Bowel cancer affects Māori and Pasifika patients at a much earlier age than non-Māori and Pasifika, so screening at a lower age makes sense, will significantly reduce the inequities in our health system and ultimately save lives,” he concludes.